A study to compare the efficacy of an extended-cycle oral contraceptive, Seasonique [ethinylestradiol/levonorgestrel + ethinylestradiol] which utilizes ethinyl estradiol during the usual hormone-free interval compared to conventional oral contraceptive therapy [ethinylestradiol/levonorgestrel] for cyclic pelvic pain

Trial Profile

A study to compare the efficacy of an extended-cycle oral contraceptive, Seasonique [ethinylestradiol/levonorgestrel + ethinylestradiol] which utilizes ethinyl estradiol during the usual hormone-free interval compared to conventional oral contraceptive therapy [ethinylestradiol/levonorgestrel] for cyclic pelvic pain

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Oct 2011

At a glance

  • Drugs Ethinylestradiol (Primary) ; Ethinylestradiol/levonorgestrel (Primary)
  • Indications Dysmenorrhoea
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 21 Jul 2009 Actual end date (1 Jul 2007) added as reported by ClinicalTrials.gov
    • 21 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 08 Nov 2008 Results were reported at the 64th Annual Meeting of the American Society for Reproductive Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top